Skip to content

G & PHarma

Active Risk: not assessed
Private limited companyfounded 200818 yrs activeLoksbergenstraat 61, 3545 Halen, BelgiumKBO/BCE: BE 0895.026.720
Summary

G & PHarma is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2024 annual accounts show equity of €517,418 and a net result of €27,997. Equity is shrinking by ~5.5% per year across the filed fiscal years. Its solvency ranks better than 44% of 6167 sector peers (fiscal year 2024). The company has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Outside the general model
Model not applicable to financial institutions
The Checked score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here. That is why we show no financial axes either.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Two signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Growing equity
Reported equity is higher than in 2022 and did not fall compared with 2023. These amounts do not establish the cause of the change.
NBB · annual accounts 2024
Equity per financial year
18192021222324
2018 to 2024 · latest year €517,418
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 17-07-2025, 14 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
not confirmed
2024
14 d early
2023
36 d early
2022
49 d early
2021
37 d early
2020
18 d early
2019
38 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 32 days before the deadline; the sector median for financial year 2024 is 14 days before the deadline, and 28% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

G & PHarma was incorporated on 18 January 2008.1 Total assets went from EUR 1.2 million in 2018 to EUR 1.1 million in 2024 and headcount from 1.3 to 2 full-time equivalents.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2024

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2024, abbreviated schema

Equity
€517,418▲ 5.7%
2023 · €489,420
Net result
€27,997▼ 56.0%
2023 · €63,559
Total assets
€1.1m▼ 1.5%
2023 · €1.1m
Solvency
45.9%▲ 3.2pp
2023 · 42.8%
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 64, Financial service activities, except insurance and pension funding, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20202021202220232024
Operating result€75,248▼ 36.3%€78,504▲ 4.3%€124,183▲ 58.2%€113,973▼ 8.2%€81,338▼ 28.6%
Net result€49,618within the sector's middle half▼ 30.7%€47,095within the sector's middle half▼ 5.1%€78,363within the sector's middle half▲ 66.4%€63,559within the sector's middle half▼ 18.9%€27,997within the sector's middle half▼ 56.0%
Equity€476,404within the sector's middle half▼ 31.0%€439,499within the sector's middle half▼ 7.7%€425,862within the sector's middle half▼ 3.1%€489,420within the sector's middle half▲ 14.9%€517,418within the sector's middle half▲ 5.7%
Total assets€1.2mwithin the sector's middle half▲ 0.1%€1.2mwithin the sector's middle half▲ 0.3%€1.1mwithin the sector's middle half▼ 8.3%€1.1mwithin the sector's middle half▲ 2.2%€1.1mwithin the sector's middle half▼ 1.5%
Debt€741,294▲ 40.9%€782,023▲ 5.5%€694,685▼ 11.2%€655,255▼ 5.7%€609,563▼ 7.0%
Working capital-€385,742below the sector's middle half▼ 266%-€481,885below the sector's middle half▼ 24.9%-€556,494below the sector's middle half▼ 15.5%-€559,234below the sector's middle half▼ 0.5%-€517,039below the sector's middle half▲ 7.5%
Solvency39.1%within the sector's middle half▼ 17.6pp36.0%within the sector's middle half▼ 3.1pp38.0%within the sector's middle half▲ 2.0pp42.8%within the sector's middle half▲ 4.8pp45.9%within the sector's middle half▲ 3.2pp
Current ratio0.29below the sector's middle half▼ 0.310.25below the sector's middle half▼ 0.040.09below the sector's middle half▼ 0.160.09below the sector's middle half▼ 0.010.08below the sector's middle half▼ 0.01
Return on assets (ROA)4.1%within the sector's middle half▼ 1.8pp3.9%within the sector's middle half▼ 0.2pp7.0%within the sector's middle half▲ 3.1pp5.6%within the sector's middle half▼ 1.4pp2.5%within the sector's middle half▼ 3.1pp
Staff (FTE)1.4within the sector's middle half▼ 6.7%1.5within the sector's middle half▲ 7.1%1.7within the sector's middle half▲ 13.3%1.7above the sector's middle half=2above the sector's middle half▲ 17.6%
above within below the middle half (P25 to P75) of NACE 64, Financial service activities, except insurance and pension funding, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50,000€100,000Operating result 2020: €75,248€75,248Net result 2020: €49,618€49,618Operating result 2021: €78,504€78,504Net result 2021: €47,095€47,095Operating result 2022: €124,183€124,183Net result 2022: €78,363€78,363Operating result 2023: €113,973€113,973Net result 2023: €63,559€63,559Operating result 2024: €81,338€81,338Net result 2024: €27,997€27,99720202021202220232024€0€50,000€100,000Operating result 2022: €124,183€124,000Net result 2022: €78,363€78,400Operating result 2023: €113,973€114,000Net result 2023: €63,559€63,600Operating result 2024: €81,338€81,300Net result 2024: €27,997€28,000202220232024
The operating result has fallen two years in a row; 2024 is 29% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €1.1m
Fixed assets €1.1m ▼ 0.6%
Current assets €41,945 ▼ 20.7%
Equity and liabilities €1.1m
Equity €517,418 ▲ 5.7%
Debt €609,563 ▼ 7.0%
Debt's share of the balance-sheet total falls from 57.2% to 54.1%. Equity is higher and debt is lower.
Key figures and ratios
2024 value · change against 2023
ROE
5.4%▼
2023 · 13.0%
Debt ≤ 1 year
€558,985▼
2023 · €612,112
Debt > 1 year
€11,077▼
2023 · €18,453
Income taxes
€11,907▼
2023 · €24,882
Staff costs
€142,959▲
2023 · €115,300
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2024 against 2023 · 54 lines
Balance sheet Code20232024
Assets
Total assets20/58€1.1m€1.1m▼
Fixed assets21/28€1.1m€1.1m▼
Tangible fixed assets22/27€29,702€22,941▼
Furniture and vehicles24€29,702€22,941▼
Financial fixed assets28€1.1m€1.1m=
Current assets29/58€52,878€41,945▼
Amounts receivable within one year40/41€48,322€33,269▼
Trade receivables40€25,367€0▼
Other amounts receivable41€22,955€33,269▲
Cash at bank and in hand54/58€1,215€5,622▲
Deferred charges and accrued income490/1€3,342€3,055▼
Equity and liabilities
Total equity and liabilities10/49€1.1m€1.1m▼
Equity10/15€489,420€517,418▲
Contributions10/11€114,000€114,000=
Reserves13€375,420€403,418▲
Non-distributable reserves130/1€0-
Reserves not available under the articles1311€0-
Distributable reserves133€375,420€403,418▲
Profit (loss) carried forward14€0-
Amounts payable17/49€655,255€609,563▼
Amounts payable after more than one year17€18,453€11,077▼
Financial debts170/4€18,453€11,077▼
Amounts payable within one year42/48€612,112€558,985▼
Current portion of amounts payable after more than one year42€71,307€7,376▼
Financial debts43€11,818€11,833▲
Credit institutions430/8€11,818€11,833▲
Trade debts44€2,734€3,284▲
Suppliers440/4€2,734€3,284▲
Taxes, remuneration and social security45€29,921€36,720▲
Taxes450/3€6,122€8,262▲
Remuneration and social security454/9€23,799€28,458▲
Other amounts payable47/48€496,331€499,772▲
Accrued charges and deferred income492/3€24,689€39,502▲
Income statement Code20232024
Non-recurring operating income76A€3,306€0▼
Remuneration, social security and pensions62€115,300€142,959▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3,964€6,761▲
Other operating charges640/8€1,755€1,619▼
Gross operating margin9900€234,993€232,677▼
Operating profit (loss)9901€113,973€81,338▼
Financial income75/76B€519€0▼
Recurring financial income75€519€0▼
Financial charges65/66B€26,051€41,434▲
Recurring financial charges65€26,051€41,434▲
Profit (loss) for the period before taxes9903€88,441€39,904▼
Income taxes67/77€24,882€11,907▼
Profit (loss) for the period9904€63,559€27,997▼
Profit (loss) for the period to be appropriated9905€63,559€27,997▼
Appropriation of the result
Profit (loss) to be appropriated9906€63,559€27,997▼
Transfer from equity791/2€0-
Transfer to equity691/2€63,559€27,997▼
To other reserves6921€63,559€27,997▼
Profit to be distributed694/7€0-
Return on contributions (dividend)694€0-
Social balance
Average headcount (FTE)90871.72.0▲

The notes to these accounts (15 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20202021202220232024Change
Non-recurring operating income76A---€3,306€0▼ 100%
Remuneration, social security and pensions62-€73,374€104,037€115,300€142,959▲ 24.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€229€229€139€3,964€6,761▲ 70.5%
Other operating charges640/8-€1,460€1,638€1,755€1,619▼ 7.8%
Gross operating margin9900€162,869€153,567€229,997€234,993€232,677▼ 1.0%
Operating profit (loss)9901€75,248€78,504€124,183€113,973€81,338▼ 28.6%
Financial income75/76B-€0€2,747€519€0▼ 100.0%
Recurring financial income75-€0€2,747€519€0▼ 100.0%
Financial charges65/66B-€12,699€16,858€26,051€41,434▲ 59.0%
Recurring financial charges65€6,234€12,699€16,858€26,051€41,434▲ 59.0%
Profit (loss) for the period before taxes9903€69,014€65,805€110,072€88,441€39,904▼ 54.9%
Income taxes67/77€19,396€18,710€31,709€24,882€11,907▼ 52.1%
Profit (loss) for the period9904€49,618€47,095€78,363€63,559€27,997▼ 56.0%
Profit (loss) for the period to be appropriated9905€49,618€47,095€78,363€63,559€27,997▼ 56.0%
Line20202021202220232024Change
Assets
Total assets20/58€1.2m€1.2m€1.1m€1.1m€1.1m▼ 1.5%
Fixed assets21/28€1.1m€1.1m€1.1m€1.1m€1.1m▼ 0.6%
Tangible fixed assets22/27€229€0€1,156€29,702€22,941▼ 22.8%
Furniture and vehicles24-€0€1,156€29,702€22,941▼ 22.8%
Financial fixed assets28€1.1m€1.1m€1.1m€1.1m€1.1m=
Current assets29/58€155,374€159,427€57,296€52,878€41,945▼ 20.7%
Amounts receivable within one year40/41€148,989€145,498€53,982€48,322€33,269▼ 31.2%
Trade receivables40-€142,894€22,748€25,367€0▼ 100%
Other amounts receivable41-€2,604€31,234€22,955€33,269▲ 44.9%
Cash at bank and in hand54/58€5,676€13,168€2,517€1,215€5,622▲ 363%
Deferred charges and accrued income490/1-€762€796€3,342€3,055▼ 8.6%
Equity and liabilities
Total equity and liabilities10/49€1.2m€1.2m€1.1m€1.1m€1.1m▼ 1.5%
Equity10/15€476,404€439,499€425,862€489,420€517,418▲ 5.7%
Contributions10/11-€114,000€114,000€114,000€114,000=
Reserves13€362,404€325,499€311,862€375,420€403,418▲ 7.5%
Non-distributable reserves130/1-€11,400€11,400€0--
Reserves not available under the articles1311-€11,400€11,400€0--
Distributable reserves133-€314,099€300,462€375,420€403,418▲ 7.5%
Profit (loss) carried forward14-€0€0€0--
Amounts payable17/49€741,294€782,023€694,685€655,255€609,563▼ 7.0%
Amounts payable after more than one year17€195,547€130,029€64,282€18,453€11,077▼ 40.0%
Financial debts170/4-€130,029€64,282€18,453€11,077▼ 40.0%
Amounts payable within one year42/48€541,117€641,312€613,790€612,112€558,985▼ 8.7%
Current portion of amounts payable after more than one year42-€65,517€65,748€71,307€7,376▼ 89.7%
Financial debts43-€4,013€11,706€11,818€11,833▲ 0.1%
Credit institutions430/8-€4,013€11,706€11,818€11,833▲ 0.1%
Trade debts44€27,625€26,958€1,316€2,734€3,284▲ 20.1%
Suppliers440/4-€26,958€1,316€2,734€3,284▲ 20.1%
Taxes, remuneration and social security45-€18,834€21,691€29,921€36,720▲ 22.7%
Taxes450/3-€9,034€8,463€6,122€8,262▲ 35.0%
Remuneration and social security454/9-€9,800€13,228€23,799€28,458▲ 19.6%
Other amounts payable47/48-€525,990€513,330€496,331€499,772▲ 0.7%
Accrued charges and deferred income492/3-€10,681€16,613€24,689€39,502▲ 60.0%
Line20202021202220232024Change
Profit (loss) for the period9904€49,618€47,095€78,363€63,559€27,997▼ 56.0%
+ Depreciation and write-downs630€229€229€139€3,964€6,761▲ 70.5%
Operating cash flow (approximation)€49,847€47,324€78,502€67,523€34,758▼ 48.5%
Investment in fixed assets (approximation)-€0-€1,295-€32,511€0▲ 100%
Change in cash-€7,492-€10,650-€1,303€4,407▲ 438%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2025
17-07
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial Weakest financial yearnet €27,997 ▼56%
Net result drops to €27,997, the lowest in the series.
31-12
Financial Equity above €500,000Eq €517,418 ▲5.7%
7 profitable years in a row build equity to €517,418.
25-06
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
12-06
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial Highest result since 2018net €78,363 ▲66.4%
Operating result €124,183, net result €78,363, both a record.
24-06
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
13-07
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
23-06
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
26-06
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
25-07
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
07-07
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
2016
06-07
NBB filing Annual accounts filed
fiscal year 2015 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 6 acts read
About the unread acts

We know of 6 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
6 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Halen · 1 establishment unit since 2008
seat establishment The establishment unit on the map
Ground area
1,126 m²
Building footprint
257 m²
Volume, LiDAR
1,742 m³
Parcel 71422B0483/00Y005, Flanders · tallest building 9.8 m, ±2 floors. Linked by address, not a title deed.
2 companies at this address See who is registered here
1 establishment unit
G & P Pharma
Loksbergenstraat 61, 3545 HalenHoldings
since 20082.168.379.867
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
71422B0483/00Y005 Flanders 1,126 m² 1 · 257 m² 9.8 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Owners and holdings

1 holding

Owners 0

The accounts to 31-12-2024 list no shareholders, and no other source names one.

Holdings 1

According to the 2024 annual accounts of G & PHarma and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Similar companies · same sector, comparable size

Of 24,729 companies in sector 64210 we hold annual accounts for 19,799. 13,609 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded18-01-2008
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
64210Activities of holding companies
E-invoicing
Reachable via Peppol
Peppol ID 0208:0895026720
Also 9925:BE0895026720
Registered 30-08-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 28 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.